Synergy Pharmaceuticals, Inc. (SGYP)
(Delayed Data from NSDQ)
$0.03 USD
0.00 (0.00%)
Updated Mar 7, 2019 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[SGYP]
Reports for Purchase
Showing records 1 - 20 ( 197 total )
Industry: Medical - Drugs
Biotechnology- Recent Drug Launch Weekly Retail Sales Tracker - Week Ended February 1
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for SGYP
Provider: ValuEngine, Inc
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending August 10
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
2Q18 Results Reported; Top and Bottom-Line Beat; Trulance Accelerating; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Drugs
Plecanatide China Licensing Agreement Inked; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Plecanatide Profile Advantages Showcased at Digestive Disease Week; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending May 25
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
1Q 2018 Financial Results Reported; Revenue Miss; Bottom-Line Beat; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Drugs
Revising Estimates Moderately to Reflect Trulance-Related Spending; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending April 20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending March 30
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending March 16
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D